Trial List
List all clinical trials by discovery date. Accepts regular expressions in search.
GET /trials/
{ "count": 814, "next": "http://api.gregory-ms.com/trials/?page=2", "previous": null, "results": [ { "trial_id": 538542, "title": "A phase III, randomized, double-blind, placebo-controlled, multicenter clinical trial of Rebif New Formulation (44 mcg tiw and 44 mcg ow) in subjects at high risk of converting to Multiple Sclerosis", "summary": "<p>EudraCT Number: 2006-002982-38<br />Sponsor Protocol Number: 27025<br />Sponsor Name: Merck Serono S.A.-Geneva, an affiliate of Merck KGaA Darmstadt, Germany<br />Start Date: 2006-11-29<br />Medical condition: Subjects at high risk of converting to Multiple Sclerosis<br />Disease: <br />Version: 9.0<br />SOC Term: <br />Classification Code: 10028245<br />Term: <br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/BE\">BE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/CZ\">CZ</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/AT\">AT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/LT\">LT</a> (Prematurely Ended), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/SK\">SK</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DE\">DE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FI\">FI</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/FR\">FR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/EE\">EE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/DK\">DK</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/IT\">IT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/GR\">GR</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/PT\">PT</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2006-002982-38/ES\">ES</a> (Completed)</p>", "published_date": null, "discovery_date": "2023-06-08T11:10:42.583956Z", "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number%3A2006-002982-38", "source": "European Clinical Trials Register", "relevant": null, "identifiers": { "nct": null, "euct": "2006-002982-38", "eudract": "2006-002982-38" }, "categories": [] }, { "trial_id": 538435, "title": "Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration", "summary": "<b>Conditions</b>: Multiple Sclerosis; Primary Progressive Multiple Sclerosis; Secondary-progressive Multiple Sclerosis<br /><b>Interventions</b>: Drug: Metformin Hydrochloride 850 mg Oral Tablet; Drug: Placebo<br /><b>Sponsors</b>: University Hospital, Antwerp; University Hospital, Ghent; Hasselt University; AZ Sint-Jan AV; Noorderhart Pelt; National MS Center Melsbroek<br /><b>Not yet recruiting</b>", "published_date": "2023-06-07T16:00:00Z", "discovery_date": "2023-06-07T12:50:42.279113Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05893225?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05893225", "euct": null, "eudract": null }, "categories": [ { "category_id": 6, "category_description": "", "category_name": "Metformin", "category_slug": "metformin", "category_terms": [ "metformin" ] } ] }, { "trial_id": 538285, "title": "MS Fatigue and tDCS on Fatigue in Multiple Sclerosis", "summary": "<b>Condition</b>: Fatigue in Multiple Sclerosis<br /><b>Interventions</b>: Procedure: Real left prefrontal tDCS - sham; Procedure: Sham - Real left prefrontal tDCS<br /><b>Sponsor</b>: Assistance Publique - Hôpitaux de Paris<br /><b>Recruiting</b>", "published_date": "2023-06-06T16:00:00Z", "discovery_date": "2023-06-06T12:50:42.940754Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05890885?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05890885", "euct": null, "eudract": null }, "categories": [] }, { "trial_id": 538128, "title": "Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Interventions</b>: Behavioral: Seated Physical activity INtervention for persons with MS, \"SPIN\" program- Intervention Condition; Behavioral: Wellness for MS (WellMS)- Control Condition<br /><b>Sponsors</b>: University of North Texas, Denton, TX; University of Illinois at Chicago; Craig Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>", "published_date": "2023-06-05T16:00:00Z", "discovery_date": "2023-06-05T13:30:45.596685Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05888727?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05888727", "euct": null, "eudract": null }, "categories": [] }, { "trial_id": 538100, "title": "An open-label, multicenter, biomarker study to explore the mechanism of action of ocrelizumab and B-cell biology in patients with relapsing multiple sclerosis or primary progressive multiple sclero...", "summary": "<p>EudraCT Number: 2015-004616-37<br />Sponsor Protocol Number: ML29966<br />Sponsor Name: GENENTECH Inc.<br />Start Date: 2016-08-03<br />Medical condition: Relapsing Multiple Sclerosis (RMS)/Primary Progressive Multiple Sclerosis (PPMS)<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063401<br />Term: Primary progressive multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004616-37/SE\">SE</a> (Completed), <a href=\"https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-004616-37/DE\">DE</a> (Completed)</p>", "published_date": null, "discovery_date": "2023-06-05T09:00:45Z", "link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number%3A2015-004616-37", "source": "European Clinical Trials Register", "relevant": null, "identifiers": { "nct": null, "euct": "2015-004616-37", "eudract": "2015-004616-37" }, "categories": [ { "category_id": 8, "category_description": "", "category_name": "Ocrelizumab", "category_slug": "ocrelizumab", "category_terms": [ "ocrelizumab", "ocrevus" ] } ] }, { "trial_id": 536707, "title": "Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises", "summary": "<b>Conditions</b>: Multiple Sclerosis; Ataxia<br /><b>Interventions</b>: Device: paraspinal vibration; Device: gastrosoleus muscle complex vibration; Other: Control Exercise<br /><b>Sponsor</b>: Hacettepe University<br /><b>Enrolling by invitation</b>", "published_date": "2023-06-01T16:00:00Z", "discovery_date": "2023-06-01T13:20:47.096553Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05885282?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05885282", "euct": null, "eudract": null }, "categories": [] }, { "trial_id": 536280, "title": "Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability", "summary": "<b>Conditions</b>: Inflammation; Spinal Cord Injuries; Multiple Sclerosis; Muscular Dystrophies; Diet Habit<br /><b>Intervention</b>: Behavioral: Mad Dog Dietary Consultation<br /><b>Sponsor</b>: Brock University<br /><b>Completed</b>", "published_date": "2023-05-31T16:00:00Z", "discovery_date": "2023-05-31T14:20:33.991777Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05881122?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05881122", "euct": null, "eudract": null }, "categories": [] }, { "trial_id": 536279, "title": "Study to Evaluate the Maintenance of Efficacy When Transitioning From Anti-CD20 Therapy to Ublituximab (ENHANCE)", "summary": "<b>Condition</b>: Relapsing Multiple Sclerosis<br /><b>Intervention</b>: Biological: Ublituximab<br /><b>Sponsor</b>: TG Therapeutics, Inc.<br /><b>Recruiting</b>", "published_date": "2023-05-26T16:00:00Z", "discovery_date": "2023-05-31T14:20:33.978062Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05877963?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05877963", "euct": null, "eudract": null }, "categories": [ { "category_id": 34, "category_description": "sg", "category_name": "Ublituximab", "category_slug": "ublituximab", "category_terms": [ "Ublituximab" ] } ] }, { "trial_id": 535846, "title": "The Effect of the Level of Hand Fatigability on Multiple Sclerosis on General Fatigue and Functionality", "summary": "<b>Conditions</b>: Fatigue; Functionality; Multiple Sclerosis; Dexterity<br /><b>Intervention</b>: Diagnostic Test: Nine-Hole Peg Test (NHPT)<br /><b>Sponsor</b>: Pamukkale University<br /><b>Completed</b>", "published_date": "2023-05-30T16:00:00Z", "discovery_date": "2023-05-30T12:40:45.850455Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05880745?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05880745", "euct": null, "eudract": null }, "categories": [] }, { "trial_id": 534031, "title": "The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br /><b>Interventions</b>: Behavioral: Split-belt Treadmill; Device: Transcutaneous Electrical Nerve Stimulation (TENS)<br /><b>Sponsors</b>: Colorado State University; National Multiple Sclerosis Society<br /><b>Not yet recruiting</b>", "published_date": "2023-05-26T16:00:00Z", "discovery_date": "2023-05-26T13:50:46.061145Z", "link": "https://clinicaltrials.gov/ct2/show/NCT05878873?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null, "identifiers": { "nct": "NCT05878873", "euct": null, "eudract": null }, "categories": [] } ] }